| William A Smith Jr, MD | |
|
2021 N Macarthur Blvd, Ste 325, Irving, TX 75061 | |
| (972) 253-4210 | |
| (972) 253-2510 |
| Full Name | William A Smith Jr |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 16 Years |
| Location | 2021 N Macarthur Blvd, Irving, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629230552 | NPI | - | NPPES |
| 3248452 01 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | P7572 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center Grapevine | Grapevine, TX | Hospital |
| Baylor Medical Center At Trophy Club | Trophy club, TX | Hospital |
| Texas Health Harris Methodist Hospital Alliance | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Clinics Of North Texas, Pllc | 5496736415 | 68 |
News Archive
Light chain amyloidosis, a deadly protein misfolding disease, is caused by multiple mutations in cells that are intended to protect the body. Instead, the mutations send misfolded bundles of proteins through the bloodstream, potentially destroying the heart, kidneys, liver or other organs. Mayo Clinic researchers have identified one of these mutations and have shown that the molecule's shifting position is as important as its unique shape. The findings appear in the current issue of the journal Structure.
Stem cells can generate any type of cell in the body, but they are inactive most of the time-and for good reason. When stem cells become too active and divide too often, they risk acquiring cell damage and mutations.
Molecular Detection Inc., a company developing Detect-Ready® tests designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has completed a $1.9 million Series B recapitalization financing.
Researchers have found that an important chemical compound, nitric oxide, appears to slow or reverse the aging of eggs in mouse ovaries. The finding suggests nitric oxide could one day help women in their 30s and 40s remain fertile longer and increase their chances of having healthy babies, the scientists say.
Australian oncology drug development company Novogen Limited and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity.
› Verified 1 days ago
| Entity Name | Urology Clinics Of North Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780971549 PECOS PAC ID: 5496736415 Enrollment ID: O20040526000711 |
News Archive
Light chain amyloidosis, a deadly protein misfolding disease, is caused by multiple mutations in cells that are intended to protect the body. Instead, the mutations send misfolded bundles of proteins through the bloodstream, potentially destroying the heart, kidneys, liver or other organs. Mayo Clinic researchers have identified one of these mutations and have shown that the molecule's shifting position is as important as its unique shape. The findings appear in the current issue of the journal Structure.
Stem cells can generate any type of cell in the body, but they are inactive most of the time-and for good reason. When stem cells become too active and divide too often, they risk acquiring cell damage and mutations.
Molecular Detection Inc., a company developing Detect-Ready® tests designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has completed a $1.9 million Series B recapitalization financing.
Researchers have found that an important chemical compound, nitric oxide, appears to slow or reverse the aging of eggs in mouse ovaries. The finding suggests nitric oxide could one day help women in their 30s and 40s remain fertile longer and increase their chances of having healthy babies, the scientists say.
Australian oncology drug development company Novogen Limited and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity.
› Verified 1 days ago
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Light chain amyloidosis, a deadly protein misfolding disease, is caused by multiple mutations in cells that are intended to protect the body. Instead, the mutations send misfolded bundles of proteins through the bloodstream, potentially destroying the heart, kidneys, liver or other organs. Mayo Clinic researchers have identified one of these mutations and have shown that the molecule's shifting position is as important as its unique shape. The findings appear in the current issue of the journal Structure.
Stem cells can generate any type of cell in the body, but they are inactive most of the time-and for good reason. When stem cells become too active and divide too often, they risk acquiring cell damage and mutations.
Molecular Detection Inc., a company developing Detect-Ready® tests designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has completed a $1.9 million Series B recapitalization financing.
Researchers have found that an important chemical compound, nitric oxide, appears to slow or reverse the aging of eggs in mouse ovaries. The finding suggests nitric oxide could one day help women in their 30s and 40s remain fertile longer and increase their chances of having healthy babies, the scientists say.
Australian oncology drug development company Novogen Limited and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity.
› Verified 1 days ago
| Entity Name | Dr Robert Stroud, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649542168 PECOS PAC ID: 0446419394 Enrollment ID: O20120312000842 |
News Archive
Light chain amyloidosis, a deadly protein misfolding disease, is caused by multiple mutations in cells that are intended to protect the body. Instead, the mutations send misfolded bundles of proteins through the bloodstream, potentially destroying the heart, kidneys, liver or other organs. Mayo Clinic researchers have identified one of these mutations and have shown that the molecule's shifting position is as important as its unique shape. The findings appear in the current issue of the journal Structure.
Stem cells can generate any type of cell in the body, but they are inactive most of the time-and for good reason. When stem cells become too active and divide too often, they risk acquiring cell damage and mutations.
Molecular Detection Inc., a company developing Detect-Ready® tests designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has completed a $1.9 million Series B recapitalization financing.
Researchers have found that an important chemical compound, nitric oxide, appears to slow or reverse the aging of eggs in mouse ovaries. The finding suggests nitric oxide could one day help women in their 30s and 40s remain fertile longer and increase their chances of having healthy babies, the scientists say.
Australian oncology drug development company Novogen Limited and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William A Smith Jr, MD 2021 N Macarthur Blvd, Irving, TX 75061-2219 Ph: (972) 253-4354 | William A Smith Jr, MD 2021 N Macarthur Blvd, Ste 325, Irving, TX 75061 Ph: (972) 253-4210 |
News Archive
Light chain amyloidosis, a deadly protein misfolding disease, is caused by multiple mutations in cells that are intended to protect the body. Instead, the mutations send misfolded bundles of proteins through the bloodstream, potentially destroying the heart, kidneys, liver or other organs. Mayo Clinic researchers have identified one of these mutations and have shown that the molecule's shifting position is as important as its unique shape. The findings appear in the current issue of the journal Structure.
Stem cells can generate any type of cell in the body, but they are inactive most of the time-and for good reason. When stem cells become too active and divide too often, they risk acquiring cell damage and mutations.
Molecular Detection Inc., a company developing Detect-Ready® tests designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has completed a $1.9 million Series B recapitalization financing.
Researchers have found that an important chemical compound, nitric oxide, appears to slow or reverse the aging of eggs in mouse ovaries. The finding suggests nitric oxide could one day help women in their 30s and 40s remain fertile longer and increase their chances of having healthy babies, the scientists say.
Australian oncology drug development company Novogen Limited and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity.
› Verified 1 days ago
Dr. Kara Choate, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2021 N Macarthur Blvd Ste 450, Irving, TX 75061 Phone: 866-367-8768 | |
Keith A Waguespack, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2021 N Macarthur Blvd Ste 450, Irving, TX 75061 Phone: 866-367-8768 Fax: 817-541-9301 | |
Lawrence J Alter, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 7200 State Highway 161, Suite 200, Irving, TX 75039 Phone: 817-303-4521 Fax: 972-401-4930 | |
Zachary Robinson Compton, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2021 N Macarthur Blvd Ste 450, Irving, TX 75061 Phone: 866-367-8768 Fax: 817-541-9301 | |
Keith D Bloom, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2021 N Macarthur Blvd Ste 450, Irving, TX 75061 Phone: 866-367-8768 Fax: 817-541-9301 |